Giorgio Attardo
Found 1 person in Pennsylvania
-
+92
-
+91
-
+90
-
-
+88
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sponsored by SpokeoPaid Service
Sponsored by SpokeoPaid Service
Giorgio Attardo
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Giorgio Attardo1994⚫🔵 - @giorgioattardo1
forza inter e juve merda #finoallafine 😉⚫🔵
718 followers
Giorgio Attardo - @giorgioattardo
209 followers
giorgio - @giorgioattardo976
29 followers
Giorgio Attardi - @giorgio.attardi
1 follower
Giorgiaattardo - @giorgiaattardo1_
🖤
61 followers
Giorgio Attardo
diploma itc - Nessuna azienda
Vijaya Bhasker Gondi
Sailam LLC
Sasmita Tripathy
Deputy Director, Drug Discovery Unit
Daniel Rabouin
VP Innovation and Technical Direction
Giorgio Attardo
Sponsored by PeopleLookerPaid Service
Search for Giorgio Attardo's city and state history
Search address historyKaruna hires another ex-Lilly scientist in quest to resurrect CNS drug
Fierce Biotech - Wed, 13 Mar 2019
Giorgio Attardo - @giorgio__
0 followers
Giorgio Attardo
www.crunchbase.com
Giorgio Attardo, PhD, MSc | Parkinson's Disease
Giorgio Attardo, MD, leads discovery research at Avid Radiopharmaceuticals Inc. His team has delivered several beta-amyloid tracers for exploratory clinical ...
Giorgio Attardo - Google Scholar
Giorgio Attardo. Karuna Therapeutics. Verified email at karunatx.com. ArticlesCited byPublic access. Title. Sort. Sort by citationsSort by year ...
Giorgio Attardo, Karuna Therapeutics Inc: Profile and Biography
Giorgio Attardo is Former VP:Chemistry & Preclinical Development at Karuna Therapeutics Inc. See Giorgio Attardo's compensation, career history, education, &
About - Karuna Therapeutics
GIORGIO ATTARDO, Ph.D. VICE PRESIDENT CMC AND PRECLINICAL DEVELOPMENT. Prior to joining Karuna, Dr. Attardo was vice president at Avid Radiopharmaceuticals ...
Giorgio Attardo – Senior Vice President, CMC & Preclinical ...
Giorgio Attardo. Senior Vice President, CMC & Preclinical, Bristol Myers Squibb. Boston, Massachusetts, United States. Effortlessly connect, engage, and ...
Giorgio Attardo's research works | University of Quebec in Montreal ...
Giorgio Attardo's 46 research works with 1649 citations, including: ChemInform Abstract: Synthesis and Activity of 6-Substituted Purine Linker Amino Acid ...
Giorgio Attardo Inventions, Patents and Patent Applications - Justia ...
Giorgio Attardo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents ...
Giorgio Attardo - Independent Researcher - Academia.edu
Giorgio Attardo: 1 Follower, 1 Following, 1 Research paper. Research interests: Vitamin E, Nuclear, and Starch.
Giorgio Attardo | Scholar Profiles and Rankings | ScholarGPS
Giorgio Attardo ; Affiliation. Eli Lilly and Company, Indianapolis, United States ; Field. Physical Sciences and Mathematics ; Discipline. Chemistry ; Top ...
Giorgio Attardo - Karuna Therapeutics - AD Scientific Index 2025
Giorgio Attardo ; In Karuna Therapeutics. 5. Scientists ; In United States. 458,900. Scientists ; In North America. 519,948. Scientists ; In World. 2,607,571
Giorgio Attardo - PermID
Giorgio Attardo · Person Details · Recent Professional Details (since Jan 01, 2012) · Need More Details? · Education Details ...
Giorgio Attardo's research works | Avid Radiopharmaceuticals and ...
Giorgio Attardo's 7 research works with 117 citations, including: Use of the PET ligand florbetapir for in vivo imaging of pancreatic islet amyloid deposits ...
Development and Scale-Up of an Enabling Synthetic Route to KTX ...
Giorgio Attardo. Giorgio Attardo. Bristol Myers Squibb Company, 1 Squibb Drive, New Brunswick, New Jersey 08903, United States. More by Giorgio ...
Giorgio Attardo Email & Phone Number | Karuna Therapeutics ...
Giorgio Attardo, based in Boston, MA, US, is currently a Senior Vice President, CMC and Preclinical Drug Development at Karuna Therapeutics.
Karuna hires another ex-Lilly scientist in quest to resurrect CNS drug
Karuna unveiled news of Felder's appointment alongside details of the promotion of Giorgio Attardo to the position of VP of chemistry, ...
Novel 1,3-disubstituted-5,10-dihydro-5,10-dioxo-1H-mbenzo[g ...
, E. Hinnant d , Micheal J. Luzzio d , Stuart A. Noble d , Giorgio Attardo a. Show more. Add to Mendeley. Share. Cite. https://doi.org/10.1016/S0960-894X(98) ...
Synthesis of a 5-deoxypyranoanthracycline : An entry into novel ...
, Marc Courchesne , Dieu Nguyen , Giorgio Attardo ∗. Show more. Add to Mendeley. Share. Cite. https://doi.org/10.1016/S0040-4039(00)73625-2 Get rights and ...
Regioselective synthesis of 6-substituted 2-hydroxybenzaldehyde
Boulos Zacharie, Giorgio Attardo, Nancy Barriault and Christopher Penney ... Search articles by author. Boulos Zacharie. Giorgio Attardo. Nancy Barriault.
Potent Antitumor Activity of a Novel Nucleoside Analogue, BCH ...
Birmingham, Alabama 35255-5305 [W. R. W.]. Search for other works by this author on: This Site · PubMed · Google Scholar. Giorgio Attardo. Giorgio Attardo.
Antitumor activity of troxacitabine (Troxatyl) against anthracycline ...
... Giorgio Attardo. Affiliation. 1 Shire BioChem Inc., 275 Armand-Frappier Blvd, Laval, Quebec H7V 4A7, Canada. hgourdeau@ca.shire.com. PMID: 12451476; DOI ...
New optically active 1,3‐oxathiolanes - Kraus - Wiley Online Library
Giorgio Attardo,. Giorgio Attardo. Department of Chemistry, McGill University, Montreal, Quebec, Canada. Search for more papers by this author · Dr. Jean-Louis ...
Development and Scale-Up of an Enabling Synthetic Route to KTX ...
... Giorgio Attardo , Vijaya B. Gondi *. * Email: gondib@gmail.com. ABSTRACT. Development and optimization of phase-appropriate synthetic technologies to prepare ...